We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TTOO T2 Biosystems Inc

0.16 (4.1%)
Dec 04 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 328,553
Bid Price 4.04
Ask Price 4.15
News -
Day High 4.37


52 Week Range


Day Low 3.79
Share Name Share Symbol Market Stock Type
T2 Biosystems Inc TTOO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.16 4.1% 4.06 18:59:52
Open Price Low Price High Price Close Price Previous Close
3.79 3.79 4.37 4.21 3.90
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,489 328,553 US$ 4.22 US$ 1,384,892 - 3.36 - 210.99
Last Trade Type Quantity Price Currency
18:59:52 formt 200 US$ 4.06 USD

T2 Biosystems Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
17.13M 4.05M - 22.31M -62.33M -15.39 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

T2 Biosystems News

Date Time Source News Article
11/28/202315:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of..
11/24/202315:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]
11/03/202308:00GlobeNewswire Inc.T2 Biosystems to Participate in the Canaccord Genuity..
11/01/202308:08Edgar (US Regulatory)Form 8-K - Current report
11/01/202308:00GlobeNewswire Inc.T2 Biosystems Regains Compliance with Nasdaq Listing..
10/25/202308:02Edgar (US Regulatory)Form 8-K - Current report
10/24/202315:05GlobeNewswire Inc.T2 Biosystems Highlights New Clinical Data Presented at..
10/23/202308:00Edgar (US Regulatory)Form 8-K - Current report
10/23/202308:00GlobeNewswire Inc.T2 Biosystems Announces Amendment and Extension of CRG Term..
10/20/202315:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/17/202315:31Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No TTOO Message Board. Create One! See More Posts on TTOO Message Board See More Message Board Posts

Historical TTOO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.924.373.363.73276,8130.143.57%
1 Month5.425.753.364.39287,357-1.36-25.09%
3 Months29.1146.853.3628.6836,564,105-25.05-86.05%
6 Months13.8570.003.3626.9474,225,002-9.79-70.69%
1 Year172.00210.993.3626.5239,227,812-167.94-97.64%
3 Years5,800.0018,950.003.361,098.6219,167,760-5,795.94-99.93%
5 Years22,400.0026,900.003.361,796.5113,430,461-22,395.94-99.98%

T2 Biosystems Description

T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |